【摘要】 生物技术的迅猛发展对人类疾病的诊断和治疗的影响已日益增强。在医疗领域,一些国家已经通过将生物医疗技术专利化,来实现在本国内对生物医疗技术发展的激励。然而,我国现行专利法已明确将疾病的诊断和治疗方法规定为不可专利的除外客体,而且基于实用性以及公共利益的考虑,运用生物医疗技术的疾病诊断和治疗方法在我国也不具有可专利性。通过论证生物医疗方法的实用性以及专利制度的激励作用,权衡生物医疗技术专利化与公共利益之间的关系,提出生物医疗方法应具有可专利性。更多还原

【Abstract】 The impact of the rapid development of biotechnology on the diagnosis and treatment of human diseases has been increasingly strengthened. In the medical field, some countries have already implemented incentives in their own countries for the development of biomedical technologies by patenting biomedical technologies. However, the existing patent law of our country has explicitly stipulated the method of diagnosis and treatment of diseases as an unpatentable exception, and based on practicality and public interest considerations, the methods of diagnosis and treatment of diseases using biomedical techniques are not patentable in our country also. By demonstrating the practicality of biomedical methods and the incentive effect of the patent system, the author will weigh the relationship between patenting of biomedical technologies and the public interest, and put forward that biomedical methods should be patentable.更多还原